America in Transition Pages

Friday, December 11, 2015

New NSCLC Drug Gets FDA Nod

(MedPage Today) -- Alectinib, an ALK inhibitor, is OK'd as second-line treatment

from MedPage Today Washington Watch http://ift.tt/1HYYtDC
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)